Results 81 to 90 of about 646 (125)

The clinical phenotype of anti-Th/To+ patients in systemic sclerosis: a case-control study within the European Scleroderma Trials and Research cohort. [PDF]

Ther Adv Musculoskelet Dis
Moschetti L, Rovaris S, Bonomi F, Codes-Mendez H, Martín-López M, Cacciapaglia F, Tonutti A, Galdo FD, Campochiaro C, Truchetet ME, Allanore Y, Kuwana M, Bruni C, Santos CS, Moroncini G, Caetano J, Granel B, Groseanu L, Pedretti E, Colombo E, Guerini M, Pereira Silva M, Bearzi P, Belloli L, Alegre-Sancho JJ, Maglio C, Cuomo G, Parvu M, Poormoghim H, Idolazzi L, Andréasson K, De Santis M, Iannone F, Carreira PE, Castellví I, Guiducci S, Cavazzana I, Franceschini F, Airò P, Lazzaroni MG.   +39 more
europepmc   +1 more source

Scientific poster session [PDF]

core   +1 more source

Scleroderma-like Syndrome in the Setting of Pembrolizumab Therapy for Non-Small Cell Lung Cancer: Diagnosis and Dermatologic Management. [PDF]

Case Rep Dermatol, 2022
Fattore D, Battista T, De Lucia M, Annunziata MC, Fabbrocini G.   +4 more
europepmc   +1 more source

Emphysema elevates the DETECT scores: impact on pulmonary hypertension screening and diagnosis in systemic sclerosis. [PDF]

Rheumatology (Oxford)
Sauer GM, Käs F, Mihai CM, Elhai M, Dobrota R, Becker MO, Muraru S, Hoffmann-Vold AM, Distler O, Bruni C.   +9 more
europepmc   +1 more source

Skin cancer and hyperthermia and radiotherapy - SAHARA: study protocol for a multicenter, two-arm, open-label, randomized controlled phase II non-inferiority trial. [PDF]

Trials
Arnold W, Sturz M, Batifi N, Vaupel P, Notter M, Mueller-Hübenthal B, Puric E, Brodmann S, Zwahlen D.   +8 more
europepmc   +1 more source

International Consensus Guidelines on the Safe and Evidence-Based Practice of Mesotherapy: A Multidisciplinary Statement. [PDF]

J Clin Med
Mammucari M, Russo D, Maggiori E, Rossi M, Lugli M, Marzo RD, Migliore A, Leone R, Koszela K, Varrassi G, On Behalf Of The International Expert Panel.   +10 more
europepmc   +1 more source

Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients' care pathway. [PDF]

J Scleroderma Relat Disord
Talarico R, Marinello D, Palla I, Cannizzo S, Galetti I, Farrington S, Aguilera S, Andersen J, Ceccatelli E, Cornet A, Cutillas G, Esteves M, Frank C, Leite C, Niehaus G, Perez Gomez E, Polfliet K, Sandulescu S, Schriemer R, Barsotti S, Bellando-Randone S, Beretta L, Bernardino V, Boleto G, Bombardieri S, Burmester G, Cavazzana I, Codullo V, Cutolo M, Dalm V, Damian L, Della Rossa A, Doria A, Farhat MM, Fonseca JE, Hachulla E, Houssiau F, Grazia Lazzaroni M, Limper M, Lorenzoni V, Montecucco C, Mosca M, Mouthon L, Müeller-Ladner U, Pha M, Ponte C, Spierings J, Sulli A, Taulaigo AV, Ticciati S, Tincani A, Toplak N, Trieste L, van Hagen PM, van Laar J, Vanthuyne M, Vigone B, de Vries-Bouwstra JK, Zen M, Turchetti G, Smith V, Matucci Cerinic M.   +61 more
europepmc   +1 more source

Rituximab retention rate in systemic sclerosis: a long term real-life multicentre study. [PDF]

Rheumatology (Oxford)
De Luca G, De Lorenzis E, Campochiaro C, Cacciapaglia F, Del Papa N, Zanatta E, Airò P, Lazzaroni MG, Giuggioli D, De Santis M, Alonzi G, Stano S, Binda M, Moccaldi B, Tonutti A, Cavalli S, Batani V, Natalello G, Iannone F, D'Agostino MA, Dagna L, Matucci-Cerinic M, Bosello SL.   +22 more
europepmc   +1 more source

Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis. [PDF]

Rheumatology (Oxford)
Velauthapillai A, Bootsma MFR, Bruni C, Bergmann C, Matucci-Cerinic M, Launay D, Riemekasten G, Garzanova L, Airò P, Rezus E, da Silva JAP, Del Galdo F, Hunzelmann N, Chung LS, Krasowska D, Distler O, van den Ende CHM, Vonk MC, EUSTAR Collaborators .   +18 more
europepmc   +1 more source

Ultra violet light, with special reference to its use in diseases of the skin. [PDF]

, 1926
Scovell, Jocelyn Mary Spencer
core   +1 more source